Cancer NetworkOriginal article
<![CDATA[Consolidative Radiotherapy Adds Toxicity Without Survival Benefit in SCLC]]>
Phase 2negativeNegative
AI Analysis
Summary
Phase 2 data demonstrates that consolidative thoracic radiation increases toxicity without providing survival benefit in patients with extensive-stage small cell lung cancer, leading to a recommendation against its use outside clinical trials for unselected patients.
Clinical Trial Data
Phase
2
Primary Endpoint
Not Met
Outcome Details
Consolidative thoracic radiation added toxicity without survival benefit in extensive-stage small cell lung cancer (ES-SCLC); cannot be recommended outside clinical trials for unselected patients
Importance:5/10
Sentiment:
-0.70
small cell lung cancerSCLCextensive-stageradiotherapytoxicityphase 2
Read the original article
Published by Cancer Network on July 24, 2026 2:30 PM